Iterum Therapeutics plc
ITRM
$1.03
-$0.05-4.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.13M | 14.50M | 11.72M | 18.21M | 23.93M |
| Total Receivables | 66.00K | 274.00K | 195.00K | 18.00K | 233.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 531.00K | 814.00K | 1.05M | 822.00K | 1.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 65.00K | 264.00K | 734.00K | -- | -- |
| Total Current Assets | 24.79M | 15.85M | 13.70M | 19.05M | 25.60M |
|
|
|||||
| Total Current Assets | 24.79M | 15.85M | 13.70M | 19.05M | 25.60M |
| Net Property, Plant & Equipment | 23.00K | 30.00K | 416.00K | 508.00K | 600.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 19.75M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.00K | 40.00K | 63.00K | 63.00K | 63.00K |
| Total Assets | 44.60M | 15.92M | 14.17M | 19.63M | 26.26M |
|
|
|||||
| Total Accounts Payable | 251.00K | 835.00K | 822.00K | 2.97M | 5.00M |
| Total Accrued Expenses | 2.65M | 3.49M | 2.26M | 1.86M | 7.76M |
| Short-term Debt | 14.46M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 67.00K | 13.98M | 13.31M | 12.57M | 365.00K |
| Total Finance Division Other Current Liabilities | 173.00K | 400.00K | 385.00K | 396.00K | 396.00K |
| Total Other Current Liabilities | 173.00K | 400.00K | 385.00K | 396.00K | 396.00K |
| Total Current Liabilities | 17.61M | 18.70M | 16.78M | 17.79M | 13.52M |
|
|
|||||
| Total Current Liabilities | 17.61M | 18.70M | 16.78M | 17.79M | 13.52M |
| Long-Term Debt | 31.07M | 8.73M | 8.30M | 7.89M | 18.96M |
| Short-term Debt | 14.46M | -- | -- | -- | -- |
| Capital Leases | -- | -- | 16.00K | 92.00K | 188.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 48.68M | 27.43M | 25.09M | 25.78M | 32.66M |
|
|
|||||
| Common Stock & APIC | 481.99M | 467.98M | 462.48M | 462.25M | 454.89M |
| Retained Earnings | -486.07M | -479.49M | -473.40M | -468.40M | -461.30M |
| Treasury Stock & Other | -- | 2.00K | -1.00K | -- | 1.00K |
| Total Common Equity | -4.08M | -11.51M | -10.91M | -6.15M | -6.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.08M | -11.51M | -10.91M | -6.15M | -6.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.08M | -11.51M | -10.91M | -6.15M | -6.40M |
|
|
|||||